Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2012
12/27/2012WO2012125547A3 Systems and methods for high resolution biomolecular imaging and analysis
12/27/2012WO2012124968A3 Method of identifying nucleic acid-containing object
12/27/2012WO2012124965A3 Method for assembling multiple target loci to a single nucleic acid sequence
12/27/2012WO2012122564A3 Diagnostic and sample preparation devices and methods
12/27/2012WO2012122561A3 Methods and systems for spores detection
12/27/2012WO2012122436A3 Molecular zipper tweezers and spring devices
12/27/2012WO2012122314A9 Rapid cell purification systems
12/27/2012WO2012122015A3 Selective inhibitors of tumor-initiating cells
12/27/2012WO2012121978A3 Biomarkers for the diagnosis of lacunar stroke
12/27/2012WO2012119243A3 Method and system for cell detection and analysis
12/27/2012WO2012095639A3 Methods, compositions, and kits for determing the presence/absence of a varian nucleic acid sequence
12/27/2012WO2012092054A3 Compositions and methods for identifying and differentiating viral components of multivalent shipping fever vaccines
12/27/2012WO2012088289A3 QTLs ASSOCIATED WITH AND METHODS FOR IDENTIFYING WHOLE PLANT FIELD RESISTANCE TO SCLEROTINIA
12/27/2012WO2012080816A9 Single nucleotide polymorphism associated with risk of insulin resistance development
12/27/2012WO2012080721A3 Plasma cell disorders
12/27/2012WO2012058303A3 Rapid salmonella serotyping assay
12/27/2012WO2011023373A3 Determination of elbow values for pcr for parabolic shaped curves
12/27/2012WO2010119144A3 Method for the synthesis of tail fragments of monocatenary dna from an expression vector and a universal primer, and the use thereof in hybridisation in situ
12/27/2012US20120331581 Polynucleotides and polypeptides involved in post-transcriptional gene silencing
12/27/2012US20120331578 Method for Producing Recombinant Glycoproteins Having Beta1,2-Bound Xylose Residues
12/27/2012US20120331577 Lettuce variety 79-163 rz
12/27/2012US20120331576 Pathogen Restriction Factors
12/27/2012US20120331573 DYNACTIN SUBUNIT p62 BIOMARKER FOR NEUROLOGICAL CONDITIONS
12/27/2012US20120331413 Method for managing treatment of a particular health condition that includes graphing accumulated data
12/27/2012US20120330679 Method for collecting patient health condition management data at a central server system
12/27/2012US20120330001 Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
12/27/2012US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation
12/27/2012US20120329886 Use of periostin as a novel biomarker
12/27/2012US20120329878 Phenotyping tumor-infiltrating leukocytes
12/27/2012US20120329853 Microrna-based method for anti-colorectal cancer effects and prognosis of colorectal cancer
12/27/2012US20120329786 Compounds and therapeutic uses thereof
12/27/2012US20120329761 Use of tigecycline for treatment of cancer
12/27/2012US20120329748 Activation and activators of sirt5
12/27/2012US20120329727 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
12/27/2012US20120329726 Hair Shape Susceptibility Gene
12/27/2012US20120329713 Method for determining likelihood of clinical recurrence or clinically stable disease of prostate cancer after radical prostatectomy
12/27/2012US20120329709 Production of glycoproteins
12/27/2012US20120329706 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof
12/27/2012US20120329675 Testing of Biofilm for Anti-microbial Agent Susceptibility
12/27/2012US20120329669 Use of dkk-1 protein in the cancer diagnosis
12/27/2012US20120329668 Biomarkers for Determining an Allograft Tolerant Phenotype
12/27/2012US20120329667 Epigenetic dna enrichment
12/27/2012US20120329666 Peripheral Blood Biomarkers for Idiopathic Interstitial Pneumonia and Methods of Use
12/27/2012US20120329663 14-3-3 sigma as a Biomarker of Basal Cancer
12/27/2012US20120329662 Hypoxia tumour markers
12/27/2012US20120329660 Methods and compositions for sorting and/or determining organisms
12/27/2012US20120329097 Nucleic acid amplification
12/27/2012US20120329087 Cell preparation containing mesenchymal stem cells, and method for producing same
12/27/2012US20120329086 Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
12/27/2012US20120329083 Test unit cartridge for analyte testing device
12/27/2012US20120329082 Devices, Systems and Methods For Evaluation of Hemostasis
12/27/2012US20120329081 Sampling devices and methods of use
12/27/2012US20120329078 Method of diagnosing cancer using g-csf protein having a deletion of an amino acid sequence corresponding to exon 3 as a diagnostic cancer marker
12/27/2012US20120329067 Methods of Generating Zinc Finger Nucleases Having Altered Activity
12/27/2012US20120329066 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
12/27/2012US20120329065 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer
12/27/2012US20120329064 Enrichment of nucleic acid targets
12/27/2012US20120329063 Novel means for the diagnosis and therapy of ctcl
12/27/2012US20120329061 Quantitative rt-pcr detection for genes involved in epithelial mesenchymal transition in peripheral blood of cancer patients
12/27/2012US20120329060 Diagnostic for lung cancer using mirna
12/27/2012US20120329059 Method for constructing novel bacterium belonging to the genus bifidobacterium
12/27/2012US20120329057 Beef-specific age determination marker containing the p21 protein
12/27/2012US20120329056 Methods of evaluating relapse risk of acute myeloid leukemia using nucleic acids or fragments encoding flt3 kinase
12/27/2012US20120329055 Use of alpha1g subunit of t-type calcium channel as diagnostic marker for pregnancy in cattle
12/27/2012US20120329054 Method and substances for isolating mirnas
12/27/2012US20120329053 MicroRNA Fingerprints During Human Megakaryocytopoiesis
12/27/2012US20120329052 Identification of a dna variant associated with adult type hypolactasia
12/27/2012US20120329051 Methods of evaluating cells and cell cultures
12/27/2012US20120329050 Methods for the detection of microorganisms
12/27/2012US20120329049 Bcr-abl1 splice variants and uses thereof
12/27/2012US20120329048 Authentication method of dairy products
12/27/2012US20120329047 Methods and assays for the detection of alternative lengthening of telomeres (alt) activity in cells
12/27/2012US20120329046 Molecular marker for evaluating pathological conditions and treatment of muscular dystrophy
12/27/2012US20120329045 Risk assessment for phenytoin-induced adverse drug reactions
12/27/2012US20120329041 Real-time pcr point mutation assays for detecting hiv-1 resistance to antiviral drugs
12/27/2012US20120329040 Microfluidic devices and methods for separating and detecting constituents in a fluid sample
12/27/2012US20120329039 Substance determining apparatus
12/27/2012US20120329038 Multivolume Devices, Kits and Related Methods for quantification of Nucleic Acids and Other Analytes
12/27/2012US20120329037 Biosensor
12/27/2012US20120328834 Microfabricated elastomeric valve and pump systems
12/27/2012US20120328764 Lettuce variety 79-190 or 79-107 rz
12/27/2012US20120328714 Early detection and treatment of lung cancer
12/27/2012US20120328637 Methods and compositions for modulating the activity of the interleukin-35 receptor complex
12/27/2012US20120328635 Chaperonin 10 variants
12/27/2012US20120328633 T cell activation inhibitor, pharmaceutical composition containing same, and screening method for t cell activation inhibiting substance
12/27/2012US20120328631 Ep1 inhibition
12/27/2012US20120328630 Methods for treating and/or limiting development of diabetes
12/27/2012US20120328620 Epidermalgrowth factor receptor mutations
12/27/2012US20120328607 Genetic markers indicative of a cancer patient response to trastuzumab (herceptin)
12/27/2012US20120328603 Assays and methods using biomarkers
12/27/2012US20120328601 Modulation of Synaptic Maintenance
12/27/2012US20120328584 Biological Pacemaker
12/27/2012US20120328579 Human trophoblast stem cells and use thereof
12/27/2012US20120328546 Paxillin Stimulating Compositions and Cosmetic Uses Thereof
12/27/2012US20120328517 Kallikrein-binding "kunitz domain" proteins and analogues thereof
12/27/2012US20120325658 Detection device
12/27/2012DE102011105809A1 Determining effect of plants on room climate, preferably on relative humidity in rooms and buildings, comprises recording room climate values e.g. temperature, and setting values in relation to plant physiological factors and parameters
12/27/2012DE102006005287B4 Verfahren zum Nachweis von Zielnukleinsäuren A method for detecting target nucleic acids
12/27/2012CA2877011A1 Systems and methods for identifying a contributor's str genotype based on a dna sample having multiple contributors
12/27/2012CA2840946A1 Methods and compositions for the treatment and diagnosis of cancer
1 ... 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 ... 3003